AI-powered search
AI-powered search

Live Evaluations

Psoriasis Management Across the Spectrum: Tailoring Care for Skin of Color: PANP24

About

Psoriasis Management Across the Spectrum: Tailoring Care for Skin of Color

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC- Both Johnson & Johnson companies

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Identify the key differential clinical presentations of psoriasis in SOC

  • Describe the role of IL-23 inhibitors in the treatment of psoriasis in patients with SOC

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Terry
Terry Faleye, MPAS, PA-C

DermSurgery Associates

Houston, Texas

Tiffany
Tiffany Mayo, MD

Associate Professor

The University of Alabama at Birmingham

Dermatology Vice Chair of Diversity, Equity and Inclusion

Department Director of Clinical Trials

Birmingham, Alabama

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Terry Faleye, MPAS, PA-C

Speakers Bureau or Honoraria: Abbvie, UCB, Lilly, BMS, Sun Pharma, Regeneron and Sanofi

Tiffany Mayo, MD

Advisory Board: Abbvie, Arcutis, BMS, Bodewell, Janssen, Lilly, Leo Novartis, Pfizer, UCB

Grant/Research Support: Acelyrin, BMS, ChemoCentryx, Galderma, Janssen, Lilly, Pfizer

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved